within Pharmacolibrary.Drugs.ATC.N;

model N05CE01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.85,
    Cl             = 60 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,
    adminCount     = 1,
    Vd             = 0.0007,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0009166666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Glutethimide is a sedative-hypnotic drug, formerly used for the treatment of insomnia. It acts as a central nervous system depressant similar to barbiturates. Due to significant risk for dependence, abuse, and severe adverse effects, glutethimide is no longer in clinical use and has been withdrawn or discontinued in most countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical adult, since no modern, peer-reviewed pharmacokinetic studies with reported parameters (e.g., CL, Vd) could be located.</p><h4>References</h4><ol><li><p>Kristensen, MB (1976). Drug interactions and clinical pharmacokinetics. <i>Clinical pharmacokinetics</i> 1(5) 351–372. DOI:<a href=&quot;https://doi.org/10.2165/00003088-197601050-00003&quot;>10.2165/00003088-197601050-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/797504/&quot;>https://pubmed.ncbi.nlm.nih.gov/797504</a></p></li><li><p>Lønning, PE, et al., &amp; Ueland, PM (1985). Single-dose and steady-state pharmacokinetics of aminoglutethimide. <i>Clinical pharmacokinetics</i> 10(4) 353–364. DOI:<a href=&quot;https://doi.org/10.2165/00003088-198510040-00005&quot;>10.2165/00003088-198510040-00005</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/4042517/&quot;>https://pubmed.ncbi.nlm.nih.gov/4042517</a></p></li><li><p>Alshowaier, IA, et al., &amp; Nicholls, PJ (1999). Pharmacokinetics of S- and R-enantiomers of aminoglutethimide following oral administration of racemic drug in breast cancer patients. <i>Journal of clinical pharmacology</i> 39(11) 1136–1142. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10579143/&quot;>https://pubmed.ncbi.nlm.nih.gov/10579143</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N05CE01;
